6 Big Themes from HLTH 2021

6 Big Themes from HLTH 2021

Mona Schreiber

Our team chose HLTH 2021 as our first conference to attend since the pandemic began. It was a fantastic experience—here are 6 big takeaways.

Practicing clinicians need to be here

What’s the easiest way to get a digital health solution adopted into clinical practice? Solve a real challenge, integrate seamlessly into the clinical workflow, and enhance both patient and clinician experience (we’re taking “Do no patient harm” as a given). This might sound like a lot to strive for, but all these elements are essential. We noticed that the majority of panels and conversations at HLTH were among entrepreneurs and CXOs. While medical expertise was showcased, we didn’t hear from many practicing clinicians who see patients day in and day out about their perspectives on these trends and solutions. We at MDisrupt know that involving clinicians early and often in your healthcare solution yields better and faster adoption. So let’s stop discussing healthcare in silos and make sure all stakeholders have a seat at the table and a voice in the process of digital health development. We’re all united in addressing the same challenges.

Health equity is on everyone’s mind

New health care delivery models like telemedicine are here to stay—entrepreneurs at HLTH made that very clear. Many top payers have even announced virtual-care-specific plans to be launching soon. That’s great for those with reliable internet connection who know how to use technology. But conversations among entrepreneurs and payers revolved around how to reach those who haven’t been reached yet, to enable a more inclusive experience. This included discussions on payment models beyond self-pay and  ways to reduce barriers to health literacy based on socio-economic background. From our perspective, the conversations around health equity are important—but now it’s time to move beyond conversation and into action. 

Implementing available solutions into the current system is hard

Right now, consumers have access to a plethora of digital health solutions. But there’s a huge gap between what consumers can access and what actually gets used and is clinically useful in the healthcare setting. Furthermore, the consumer/patient experience becomes very disjointed once they bring digital health solutions to healthcare providers with no knowledge or experience of these solutions. Often the potential health outcomes and the ROI of the solution are not clear. The current solution for this is that the big players in healthcare like to test solutions with ‘Pilots” However the term “death by pilot” was heard a lot during HLTH. Our favorite quote came from Chrissy Farr’s interview with Alan Lotvin MD, who is EVP of CVS Health; he said, “Big companies in healthcare like to torture small companies.”

Payers, providers, health systems, and employers all agree that we need a better system of vetting evidence based digital health solutions. How do we solve this? At MDisrupt, we believe that missing from our industry is a unified standards system for digital health to assess the real-world clinical performance of these products. We intend to focus on this monumental challenge over the next few years.

Healthcare’s tech shift was super-accelerated by the pandemic

This was the first conference we’ve attended where a testing protocol was implemented at the conference. Every single person who attended had to be tested. And we have to credit HLTH, as the process was relatively fast and efficient. Deployment happened through an app, human guides helped us through the process, and an onsite testing system delivered results to us in 20 minutes via our apps. This is a demonstration of just how far we have come in digital health in just two years. It showed us that we can bring lab testing closer to the consumer at scale, we can make it more efficient and more convenient, we can take care of people where they live and where they work. Now that we know it can be done, imagine if this could be applied to all areas of healthcare!

Mental health is no longer an afterthought

The pandemic changed the way we think and talk about mental health. Treatment and services for conditions that were once stigmatized, with care available primarily for severe cases, are now becoming part of the norm. . Leaders in mental and behavioral health came together at HLTH to discuss improving delivery models, like telemedicine; integrating mental health practices into a complete healthcare plan, and, best of all,making these changes mainstream. There’s still a long way to go in reaching the masses, but it was clear that technology can make it happen.

The need for human connection is so real

As we registered for HLTH, we were asked to choose a wristband that signaled how you wanted to be greeted:

  • Green bands signaled that you were ok with hugs and handshakes
  • Yellow bands signaled that you preferred fist elbow bumps
  • Red bands signaled a no touch-greeting.

By the end of the first day, the basket of green bands was completely empty, with the majority of us selecting them. After two grueling pandemic years—in which many of us have been in lockdown and seen the suffering and loss of many people close to us—it was clear how much we all needed human contact. There was a lot of welcome hugging and handshaking as folks who hadn’t seen each other for over two years reconnected. The unspoken feeling between us was that we are all in this together, and that we are the changemakers for a better future.

To quote this year’s HLTH motto: ”Dear Future, we are coming for you.”

If you want to dive into more interesting topics related to healthcare, check out our blog at MDisrupt.

At MDisrupt, we believe that the most impactful health products should make it market quickly. We connect digital health innovators to the healthcare industry experts and scientists they need to responsibly accelerate product development, commercialization, adoption, and scale.

Our experts span the healthcare continuum and can assist with all stages of health product development: This includes regulatory, clinical studies and evidence generation, payor strategies, commercialization, and channel strategies. If you are building a health product, talk to us.

Why No Digital Health CEO Should Miss HLTH

Why No Digital Health CEO Should Miss HLTH

Mona Schreiber

Didn’t go to the HLTH conference? Don’t know why you should have been there? MDisrupt’s VP of Marketing Mona Schreiber shares her take on why it offers incredible opportunity for digital health CEOs.

You’re a digital health CEO, building a rockstar team, staying on top of industry trends, raising capital, and trying to keep the lights on. We get it. You’re busy! 

MDisrupt was there. We’re also a startup in the digital health space and our CEO barely sleeps because she’s navigating the same challenges. Why did we take time out of our schedules to be there? 

MDisrupt breaks it down for you:

See the latest trends

If you’re like us, you subscribe to several different newsletters/news sites to keep up on the latest trends, but never have time to read anything beyond the same two or three headlines you see pop up in your social media feeds. The HLTH conference is a three-day immersion in all the trends in digital health, the perspectives of the various healthcare stakeholders, what the future holds, and how not to be left behind. It’s like a “bootcamp into the healthcare of the future.” You can leave here more informed than if you sat down and read every single article that came out. And… it’s so much more fun this way! 

Network with other entrepreneurs

Ever ask the question – how did my peer/ Entrepreneur X solve that problem? At HLTH, you can ask them! This conference is full of founders who have walked the path before you and advisors who are ready to help others. You’re not alone. You’ll be able to meet hundreds of other digital health companies disrupting the healthcare space, all at one venue. No more googling leading you down a rathole. Meet the amazing minds behind each innovation, in person.

Meet the investors

Flying around the country to meet with individual investors isn’t the most ideal way to fundraise – especially in the middle of a pandemic. This year’s HLTH had something unusual about it that we had never seen before. The digital health space is so hot right now that investors set up booths in the exhibit hall. In fact, there were 70+ investment partners in attendance.  And they partied hard – every night the bar at the Omni was overtaken by our investor friends.  No more waiting for warm intros – HLTH was the place to be if you wanted to meet investors in a more casual setting. For now, it’s a founders market. 

Bolster your team

The team you build is the essence of your company, particularly in complex spaces like healthcare.  You need to hire amazing talent and fast – the story of every startup. What if there was a place you could go to meet these people without hiring someone to scour LinkedIn all day? Meet them all in one place. Even better, meet connectors – like MDisrupt – who can help you find the expertise you’re looking for, quickly and on demand. 

Get inspired!

It’s been a year. You and your team have accomplished so much, but you’re mentally and emotionally exhausted. There’s only so far coffee can go. What if you could meet the patients whose lives you were changing with your innovation? Bet that would get your emotional mojo going.

This conference oozes creativity in solving healthcare challenges. Our team came back with more energy and ideas after meeting and exchanging ideas with the most passionate minds in healthcare. Be there! Feel the energy. Reset. Crush it!

You missed the conference, so what now?

Step 1: Sign up for a free 30-minute consultation to discuss a project you’re working on – we have over 250 health experts who can help you tackle your challenge.
Step 2: Follow us on Linkedin and Twitter.

See you there next year!

If you want to dive into more interesting topics related to healthcare, check out our blog at MDisrupt.

At MDisrupt, we believe that the most impactful health products should make it market quickly. We connect digital health innovators to the healthcare industry experts and scientists they need to responsibly accelerate product development, commercialization, adoption, and scale.

Our experts span the healthcare continuum and can assist with all stages of health product development: This includes regulatory, clinical studies and evidence generation, payor strategies, commercialization, and channel strategies. If you are building a health product, talk to us.

The Awesome Women Scientist-Founders Transforming Digital Health

The Awesome Women Scientist-Founders Transforming Digital Health

For Women’s History Month, we wanted to celebrate the accomplishments of female scientists who have founded digital health companies. Women scientists have started some amazing companies—but until now it hasn’t been easy to find information about many of them in one place. (It’s similar to what we discovered when we created our list of female physicians who are digital health founders.)

From gene editing to therapeutics to femtech to preventive care, check out some of the exciting ways that female scientist-founded companies are innovating in digital health.

We know that there are lots more of these companies out there! If you’re a female scientist founder, and would like to be included in this list, you can add yourself by clicking the button below:

 

Jennifer Doudna, PhD

Company: Scribe Therapeutics
Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.

Twitter:
LinkedIn: Jennifer Doudna, PhD

Rupal Patel, MHSc, PhD

Company: VocaliD
We make digital voice personal. Whether you’re a brand or individual, we have the synthetic voice solution for you.

Twitter: @TweetRupal
LinkedIn: Rupal Patel

Meesha Dogon, PhD

Company: Cardio Diagnostics
At Cardio Diagnostics we are transforming heart disease prevention through ML/AI and DNA-based solutions.

Twitter:
LinkedIn: Meesha Dogan, PhD

Janice Chen, PhD

Company: Mammoth Biosciences
At Mammoth, we discover novel CRISPR systems that enable new possibilities for expanding biology.

Twitter: @janiceschen
LinkedIn: Janice Chen

Elina Berglund Scherwitzl, PhD

Company: Natural Cycles
The only FDA cleared birth control app puts the power in the palm of your hand. Skip the pharmacy, no prescription needed.

Twitter: @EScherwitzl
LinkedIn: Elina Berglund Scherwitzl

Kate Rosenbluth, PhD

Company: Cala Health
Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease.

Twitter: @KateRosenbluth
LinkedIn: Kate Rosenbluth, PhD

Marina Pavlovic Rivas, MS

Company: Eli.Health
Eli enables women to take control of their health across their lives, by providing them with their daily hormone profile.

Twitter: @data_marina
LinkedIn: Marina Pavlovic Rivas

Áine Behan, MSc, PhD

Company: Cortechs
At Cortechs, we use brain powered play and brainwaves as a tool to improve behaviours such as attention in easily distracted children that want to improve their focus.

Twitter: @cortechs_ab
LinkedIn: Áine Behan

Darlene Higbee Clarkin, RHN

Company: KORE Digital Health Therapeutics
KORE Digital Health Therapeutics is optimizing digestive health outcomes through behaviour change, progressive nutritional education and evidence-based digital therapeutics.

Twitter: 
LinkedIn: Darlene Higbee Clarkin, RHN

Raeanne Moore, PhD

Company: KeyWise AI
KeyWise AI develops AI software that tracks brain function, objectively & precisely.

Twitter: @raeannephd
LinkedIn: Raeanne Moore, PhD

Kate Wolin, ScD

Company: Coeus Health
Coeus Health unlocks the tools to provide health and wellness programs that work.

Twitter: @DrKateWolin
LinkedIn: Kate Wolin

Kiran Mazumdar Shaw, PhD

Company: Biocon
An innovation-led fully integrated biopharmaceutical company that develops affordable biosimilars, novel biologics & complex APIs

Twitter: @KiranShaw
LinkedIn: Kiran Mazumdar Shaw, PhD

Jane Wang, BSc

Company: Optimity
Optimity makes a gamified health rewards platform that applies nudge science to support a proactive approach to holistic healthy living.

Twitter: @JaneJwang
LinkedIn: Jane Wang

Maggie Bergeron, MSc

Company: Embodia
Online continuing education for physiotherapists plus digital home exercise and patient engagement software.

Twitter: @maggiebpt
LinkedIn: Maggie Bergeron

Cecile Real

Company: Endodiag
We develop new endometriosis diagnostic solutions to contribute to a better endometriosis diagnosis, a more personalized patient management, more efficient treatment options and fertility strategy.

Twitter:
LinkedIn: Cecile Real

Isabel Van De Keere, PhD

Company: Immersive Rehab
Immersive Rehab creates personalised digital therapeutics neurorehabilitation programmes in virtual reality with the aim to improve patient recovery.

Twitter: @ScienceRoadie
LinkedIn: Isabel Van De Keere, PhD

Elizabeth Iorns, PhD

Company: Science Exchange
Science Exchange, the R&D Services Management company, empowers research organizations to accelerate science and drive innovation success.

Twitter: @elizabethiorns
LinkedIn:Elizabeth Iorns, PhD

Alicia Jackson, PhD

Company: Evernow
Preventive primary care, powered by technology

Twitter:
LinkedIn: Alicia Jackson

Jennifer Doudna, PhD

Company: Mammoth Biosciences
At Mammoth, we discover novel CRISPR systems that enable new possibilities for expanding biology.

Twitter:
LinkedIn: Jennifer Doudna, PhD

Kate Wolin, ScD

Company: Circea
Circea guides clients in threading the needle between evidence and commercial need in health behavior change.

Twitter: @DrKateWolin
LinkedIn: Kate Wolin

Amanda French, BSE

Company: Emme
Emme is a healthcare technology company with a mission to put women’s health in women’s hands, starting with birth control.

Twitter:
LinkedIn:Amanda French

Claire Novorol, PhD

Company: Ada
Ada’s core system connects medical knowledge with intelligent technology to help all people actively manage their health and medical professionals to deliver effective care.

Twitter: @clairenovorol
LinkedIn: Claire Novorol

Geetha Manjunath, PhD

Company: Niramai
Niramai Health Analytix is a non-contact privacy-aware breast cancer screening solution that detects early stage breast abnormalities.

Twitter: @geethamhp
LinkedIn: Geetha Manjunath

Nabiha Saklayen, PhD

Company: Cellino
Cellino Biotech develops intracellular delivery lasers and nanotechnology for gene editing applications.

Twitter: @nabsicle
LinkedIn: Nabiha Saklayen, PhD

Parastoo Khoshakhlagh, Ph.D

Company: GC Therapeutics, Inc
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability.

Twitter: @Parastoo__KH
LinkedIn: Parastoo Khoshakhlagh, Ph.D

Mona Schreiber

Mona Schreiber, VP of Marketing, MDisrupt

Mona is a marketing leader with over 15 years b2b experience developing new healthcare markets. Prior to joining MDisrupt, she was an early marketing lead at Invitae Inc, where she helped scale the company from small startup to market leader in the nascent genetic testing industry. She brings with her a deep understanding of global markets from her international marketing work at Invitae and Affymetrix.

At MDisrupt we believe that the most impactful health products should make it to market quickly. We help make this happen by connecting digital health innovators to the healthcare industry experts and scientists they need to responsibly accelerate product development, commercialization, adoption, and scale. Our expert consultants span the healthcare continuum and can assist with all stages of health product development: This includes regulatory, clinical studies and evidence generation, payor strategies, commercialization, and channel strategies. If you are building a health product, talk to us.